Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity.

Khoury, Aleen; Sakoff, Jennette A; Gilbert, Jayne; Scott, Kieran F; Karan, Shawan; Gordon, Christopher P; Aldrich-Wright, Janice R

Khoury, Aleen; Sakoff, Jennette A; Gilbert, Jayne; Scott, Kieran F; Karan, Shawan; Gordon, Christopher P; Aldrich-Wright, Janice R.

Affiliation

Khoury A; School of Science, Western Sydney University, Locked Bag 1797, Penrith South, NSW 2751, Australia.
Sakoff JA; Calvary Mater Hospital, Waratah, NSW 2298, Australia.
Gilbert J; Calvary Mater Hospital, Waratah, NSW 2298, Australia.
Scott KF; School of Medicine, Western Sydney University, Locked Bag 1797, Penrith South, NSW 2751, Australia.
Karan S; Ingham Institute, 1 Campbell Street, Liverpool, NSW 2170, Australia.
Gordon CP; School of Science, Western Sydney University, Locked Bag 1797, Penrith South, NSW 2751, Australia.
Aldrich-Wright JR; School of Science, Western Sydney University, Locked Bag 1797, Penrith South, NSW 2751, Australia.

Pharmaceutics ; 14(4)2022 Apr 03.

Article de En | MEDLINE | ID: mdl-35456621

Mots clés

56MESS; NSAIDS; cancer; cyclooxygenase; cytotoxicity; lipophilicity; nanomolar; platinum(IV); prodrugs

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Pharmaceutics Année: 2022 Type de document: Article Pays d'affiliation: Australie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google